SEPTAX 1 G

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Beli Sekarang

Karakteristik produk Karakteristik produk (SPC)
22-11-2018

Bahan aktif:

CEFTAZIDIME AS PENTAHYDRATE

Tersedia dari:

BIOAVENIR LTD, ISRAEL

Kode ATC:

J01DD

Bentuk farmasi:

POWDER FOR SOLUTION FOR INJ/INF

Komposisi:

CEFTAZIDIME AS PENTAHYDRATE 1000 MG

Rute administrasi :

I.M, I.V

Jenis Resep:

Required

Diproduksi oleh:

VIANEX S.A, GREECE

Kelompok Terapi:

THIRD GENERATION CEPHALOSPORINS

Indikasi Terapi:

Septax is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• Nosocomial pneumonia• Broncho-pulmonary infections in cystic fibrosis• Bacterial meningitis• Chronic suppurative otitis media• Malignant otitis externa• Complicated urinary tract infections• Complicated skin and soft tissue infections• Complicated intra-abdominal infections• Bone and joint infections• Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria.Ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Tanggal Otorisasi:

2021-12-31

Peringatan pencarian terkait dengan produk ini

Lihat riwayat dokumen